Xiuning Le

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.359Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Impact of genomic aberrations and additional therapies on survival outcomes of patients with operable non-small cell lung cancer (NSCLC) from the NEOSTAR study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8542

Top 49%

0.359DataRank

Top 49%3 citations

Boris Sepesi, Cheuk Hong Leung, Heather Lin, William Nassib William, Annikka Weissferdt +15 more

Papers

Driven by 39 papers — median percentile 51. Top paper: “Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial”.

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial

The Lancet(2023)10.1016/s0140-6736(23)01384-3

N/A

5.0DataRank · unranked

230 citations

Steven H. Lin, Wenli Dong, Zhongxing Liao, Saumil Gandhi, Carl M. Gay +23 more

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Nature Medicine(2023)10.1038/s41591-022-02189-0

N/A

4.1DataRank · unranked

213 citations

Cheuk Hong Leung, Annikka Weissferdt, Apar Pataer, Brett W. Carter, Myrna C. B. Godoy +52 more

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity

Cancer Cell(2022)10.1016/j.ccell.2022.06.006

N/A

3.9DataRank · unranked

106 citations

Jacqulyne Robichaux, Brett W. Carter, Mehmet Altan, Hai T. Tran, Don L. Gibbons +22 more

Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers

The Oncologist(2022)10.1093/oncolo/oyac080

N/A

1.7DataRank · unranked

49 citations

Christina S. Baik, Jessica R. Bauman, Jill Gilbert, Marcia S. Brose, Juneko E. Grilley‐Olson +13 more

Analytical protocol to identify local ancestry-associated molecular features in cancer

STAR Protocols(2021)10.1016/j.xpro.2021.100766

N/A

0.400DataRank · unranked

9 citations

Seunghun Han, Liangtao Zheng, Jeffrey S. Damrauer, Anab Kemal, Ashton C. Berger +35 more

Impact of genomic aberrations and additional therapies on survival outcomes of patients with operable non-small cell lung cancer (NSCLC) from the NEOSTAR study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8542

Top 49%

0.359DataRank

Top 49%3 citations

Boris Sepesi, Cheuk Hong Leung, Heather Lin, William Nassib William, Annikka Weissferdt +15 more

Joint multi-omics discriminant analysis with consistent representation learning using PANDA

Research Square(2024)10.21203/rs.3.rs-4353037/v1

N/A

0.217DataRank · unranked

2 citations

Muhammad Aminu, Lingzhi Hong, Natalie I. Vokes, Stephanie Schmidt, Maliazurina B. Saad +15 more

Analysis of germline-driven ancestry-associated gene expression in cancers

STAR Protocols(2022)10.1016/j.xpro.2022.101586

N/A

0.165DataRank · unranked

2 citations

Rosalyn W. Sayaman, Donglei Hu, Scott Huntsman, Ashton C. Berger, Seunghun Han +37 more

Structure-based classification predicts drug response in EGFR-mutant NSCLC

Nature(2021)10.1038/s41586-021-03898-1

N/A

0DataRank · unranked

459 citations

Xiuning Le, R. S. K. Vijayan, J. Kevin Hicks, Simon Heeke, Yasir Y. Elamin +28 more

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002891

N/A

0DataRank · unranked

292 citations

Ferdinandos Skoulidis, Meagan Montesion, Katja Schulze, Ilze Bāra, Vincent K. Shen +33 more

Current and future treatment options for MET exon 14 skipping alterations in non-small cell lung cancer

Therapeutic Advances in Medical Oncology(2021)10.1177/1758835921992976

N/A

0DataRank · unranked

64 citations

Jianjun Zhang, John V. Heymach, Xiuning Le, Lingzhi Hong

Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer

Nature Communications(2021)10.1038/s41467-021-26821-8

N/A

0DataRank · unranked

52 citations

Runzhe Chen, Ying Jin, Jun Li, Xin Hu, Jiexin Zhang +40 more

Estrogen Promotes Resistance to Bevacizumab in Murine Models of NSCLC

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.07.007

N/A

0DataRank · unranked

20 citations

Matthew H. Herynk, Tina Cascone, Babita Saigal, Monique B. Nilsson, Hai T. Tran +8 more

1745P SARS-CoV-2 infects metabolically-primed epithelial cells in lung cancer models

Annals of Oncology(2020)10.1016/j.annonc.2020.08.1809

N/A

0DataRank · unranked

0 citations

C. Allison Stewart, Carl M. Gay, Kavya Ramkumar, Robert J. Cardnell, Monique B. Nilsson +13 more

Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1366

N/A

0DataRank · unranked

451 citations

Monique B. Nilsson, Xiuning Le, Tina Cascone, Rakesh K. Jain, John V. Heymach +1 more

Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.02.011

N/A

0DataRank · unranked

159 citations

Emily S. Chambers, Tom Nguyen, Alexis Coolidge, Christine Lydon, Xiuning Le +6 more

Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancer

Lung Cancer(2020)10.1016/j.lungcan.2020.08.023

N/A

0DataRank · unranked

20 citations

Lingzhi Hong, Monique B. Nilsson, Shawna M. Hubert, Shuhong Wu, Waree Rinsurongkawong +11 more

Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent Phenotype

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.11.022

N/A

0DataRank · unranked

73 citations

Jacqulyne Robichaux, Matthew H. Herynk, Tina Cascone, Xiuning Le, Yasir Y. Elamin +17 more

Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance

Nature Medicine(2023)10.1038/s41591-023-02371-y

N/A

0DataRank · unranked

493 citations

Enyu Dai, Yating Li, Guangchun Han, Guangsheng Pei, Davis R. Ingram +39 more

Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.12.010

N/A

0DataRank · unranked

126 citations

Marcelo V. Negrão, Alexandre Reuben, Lorenzo Federico, Lixia Diao, Daniel J. McGrail +34 more

A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components

Science Translational Medicine(2020)10.1126/scitranslmed.aaz4589

N/A

0DataRank · unranked

181 citations

Huiying Sun, Jacqulyne Robichaux, Matthias Pfeifer, Ultan McDermott, Jon Travers +19 more

Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review

International Journal of Molecular Sciences(2023)10.3390/ijms24097781

N/A

0DataRank · unranked

142 citations

Maliazurina B. Saad, Amgad Muneer, Rizwan Qureshi, Seyedali Mirjalili, Ajay Sheshadri +5 more

Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study

The Lancet Digital Health(2023)10.1016/s2589-7500(23)00082-1

N/A

0DataRank · unranked

110 citations

Lingzhi Hong, Muhammad Aminu, Natalie I. Vokes, Pingjun Chen, Morteza Salehjahromi +44 more

CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance

Cancer Cell(2023)10.1016/j.ccell.2023.01.007

N/A

0DataRank · unranked

104 citations

Yan Yang, Simon Heeke, Sonia Patel, Alissa Poteete, Hibiki Udagawa +22 more

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.11.020

N/A

0DataRank · unranked

25 citations

Robyn Du, Nathaniel J. Myall, Whitney E. Lewis, Natalie Uy, Lingzhi Hong +22 more

Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100623

N/A

0DataRank · unranked

11 citations

Whitney E. Lewis, C. Allison Stewart, Benjamin B. Morris, Luisa M. Solis, Alejandra G. Serrano +31 more

Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast

Targeted Oncology(2023)10.1007/s11523-023-01020-1

N/A

0DataRank · unranked

0 citations

Eric Nadler, Daniel B. Costa, John V. Heymach, Xiuning Le

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Nature(2024)10.1038/s41586-024-07943-7

N/A

0DataRank · unranked

165 citations

Haniel A. Araújo, Minh Truong, Yu Qian, Xin Sun, Ana Galán‐Cobo +95 more

Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights

Nature Communications(2024)10.1038/s41467-024-47512-0

N/A

0DataRank · unranked

86 citations

Muhammad Aminu, Tatiana V. Karpinets, Pingjun Chen, Maliazurina B. Saad, Morteza Salehjahromi +32 more

Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomes

Cancer Innovation(2024)10.1002/cai2.112

N/A

0DataRank · unranked

8 citations

Runzhe Chen, Yang Liu, Junya Fujimoto, Lingzhi Hong, Alexandre Reuben +20 more

Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.04.026

N/A

0DataRank · unranked

194 citations

Marcelo V. Negrão, Seyedeh Dibaj, Runzhe Chen, Alexandre Reuben, Jadi M. Bohac +32 more

Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception

Cancer Cell(2025)10.1016/j.ccell.2025.04.003

N/A

0DataRank · unranked

28 citations

Pingjun Chen, Muhammad Aminu, Jiànróng Lǐ, Junya Fujimoto, Yanhua Tian +47 more

Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC—A Real-World Case Series: Case Report

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.02.023

N/A

0DataRank · unranked

17 citations

Komal Shah, Mitchell Parma, Kaiwen Wang, Eric K. Singhi, Whitney E. Lewis +23 more

Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multicenter Retrospective Study

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.07.121

N/A

0DataRank · unranked

11 citations

Alessandro Di Federico, Bolun Liu, Alissa J. Cooper, Joao V. Alessi, Phoebe Clark +25 more

Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity

Nature Communications(2025)10.1038/s41467-025-61817-8

N/A

0DataRank · unranked

7 citations

Jacqulyne Robichaux, Monique B. Nilsson, R. S. K. Vijayan, Ashwin Ravichandran, Jia Wu +21 more

Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC

Nature Communications(2025)10.1038/s41467-025-61823-w

N/A

0DataRank · unranked

7 citations

Qasem Al-Tashi, Lingzhi Hong, Vivek Verma, Wentao Li, Daniel Boiarsky +32 more

First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1735

N/A

0DataRank · unranked

6 citations

Hui Li, Alessandro Di Federico, Jia Wu, Hong Chen, Eleonora Gariazzo +26 more

Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients

Cancers(2025)10.3390/cancers17213406

N/A

0DataRank · unranked

1 citations

Hui Li, Eman Showkatian, Maliazurina B. Saad, Mohamed Qayati, Sohair Ismail +25 more

Development of PET/CT-clinical nomograms for predicting lymph node metastasis in primary lung cancer

European Radiology(2025)10.1007/s00330-025-12166-z

N/A

0DataRank · unranked

0 citations

Wentao Li, Julie Lin, Shuoyang Li, Maliazurina B. Saad, Yuliya Kitsel +17 more

Xiuning Le

Indexed papers

Top data-sharing exemplar

Papers